Natixis Investment Managers International’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$238K Hold
2,667
0.02% 128
2024
Q3
$223K Hold
2,667
0.02% 126
2024
Q2
$205K Hold
2,667
0.02% 121
2024
Q1
$183K Buy
2,667
+308
+13% +$19.8K 0.01% 135
2023
Q4
$136K Hold
2,359
0.01% 166
2023
Q3
$125K Buy
+2,359
New +$124K 0.01% 162
2018
Q4
Sell
-27,912
Closed -$1.07M 103
2018
Q3
$1.07M Buy
27,912
+4,995
+22% +$174K 0.05% 324
2018
Q2
$749K Buy
22,917
+16,533
+259% +$499K 0.04% 333
2018
Q1
$174K Buy
+6,384
New +$174K 0.01% 374
2016
Q4
Sell
-35,634
Closed -$848K 423
2016
Q3
$848K Buy
+35,634
New +$850K 0.09% 156
2016
Q1
Sell
-26,360
Closed -$486K 365
2015
Q4
$486K Hold
26,360
0.06% 159
2015
Q3
$433K Buy
26,360
+4,141
+19% +$70.8K 0.06% 213
2015
Q2
$393K Buy
+22,219
New +$397K 0.05% 255

Other funds holding BSX

Natixis Investment Managers International's BSX Position: Q4 2024 in Review

Natixis Investment Managers International held its Boston Scientific (BSX) position steady in Q4 2024 at 2,667 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #128.

Natixis Investment Managers International first reported a position in BSX in Q2 2015 and has held it in 13 quarters since. The position peaked at $1.07M in Q3 2018. 1,513 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Natixis Investment Managers International held 2,667 shares of Boston Scientific worth $238K as of Q4 2024.
  • Natixis Investment Managers International left its Boston Scientific share count unchanged in Q4 2024.
  • Boston Scientific made up 0.02% of Natixis Investment Managers International's portfolio in Q4 2024, its #128 holding.
  • Natixis Investment Managers International first reported a position in Boston Scientific in Q2 2015 and has held it in 13 quarters since.
  • Natixis Investment Managers International's Boston Scientific position peaked at $1.07M in Q3 2018.
  • 1,513 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Natixis Investment Managers International's 13F filing for Q4 2024, filed 13 Feb 2025.